Skip to main content
Chandragouda Dodagoudar on Muck Rack

Chandragouda Dodagoudar

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chandragouda

Contact Chandragouda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience

|
By Amit Agarwal, Saphalta Baghmar, Chandragouda Dodagoudar, Suhail Qureshi
| ascopubs.org
Epithelial ovarian cancer (EOC) is the third most common gynecologic cancer among women in the world and accounts for 6.6/100,000 new cases per year, whereas in India, it is second most common gynecologic cancer among women with an age-standardized rate of 4.9/100,000.1 The majority of patients with ovarian cancer relapse after a median progression-free survival (PFS) of 12-18 months.2-13 Outcome for patients with relapse is generally poor with median PFS from 6 to 12 months, which decreases...
Open in Who Shared Issue with article?
See all 1 articles